TURIELLO, ROBERTA
TURIELLO, ROBERTA
Dipartimento di Farmacia/DIFARMA
A2A Receptor Contributes to Tumor Progression in P2X7 Null Mice
2022-01-01 De Marchi, Elena; Pegoraro, Anna; Turiello, Roberta; Di Virgilio, Francesco; Morello, Silvana; Adinolfi, Elena
Adenosine Signaling in the Tumor Microenvironment
2021-01-01 Antonioli, Luca; Fornai, Matteo; Pellegrini, Carolina; D'Antongiovanni, Vanessa; Turiello, Roberta; Morello, Silvana; Haskó, György; Blandizzi, Corrado
CD73: A Promising Biomarker in Cancer Patients
2020-01-01 Turiello, R.; Pinto, A.; Morello, S.
Enzyme activity of circulating CD73 in human serum
2019-01-01 Morello, S.; Turiello, R.; Madonna, G.; Pinto, A.; Ascierto, P. A.; Capone, M.
Exacerbation of Allergic Airway Inflammation in Mice Lacking ECTO-5′-Nucleotidase (CD73)
2020-01-01 Caiazzo, E.; Cerqua, I.; Riemma, M. A.; Turiello, R.; Ialenti, A.; Schrader, J.; Fiume, G.; Caiazza, C.; Roviezzo, F.; Morello, S.; Cicala, C.
Exosomal CD73 from serum of patients with melanoma suppresses lymphocyte functions and is associated with therapy resistance to anti-PD-1 agents
2022-01-01 Turiello, R.; Capone, M.; Morretta, E.; Monti, M. C.; Madonna, G.; Azzaro, R.; Del Gaudio, P.; Simeone, E.; Sorrentino, A.; Ascierto, P. A.; Morello, S.
Frequency of circulating CD8+CD73+T cells is associated with survival in nivolumab-treated melanoma patients
2020-01-01 Capone, M.; Fratangelo, F.; Giannarelli, D.; Sorrentino, C.; Turiello, R.; Zanotta, S.; Galati, D.; Madonna, G.; Tuffanelli, M.; Scarpato, L.; Grimaldi, A. M.; Esposito, A.; Azzaro, R.; Pinto, A.; Cavalcanti, E.; Pinto, A.; Morello, S.; Ascierto, P. A.
L-RNA aptamer-based CXCL12 inhibition combined with radiotherapy in newly-diagnosed glioblastoma: dose escalation of the phase I/II GLORIA trial
2024-01-01 Giordano, Frank A.; Layer, Julian P.; Leonardelli, Sonia; Friker, Lea L.; Turiello, Roberta; Corvino, Dillon; Zeyen, Thomas; Schaub, Christina; Müller, Wolf; Sperk, Elena; Schmeel, Leonard Christopher; Sahm, Katharina; Oster, Christoph; Kebir, Sied; Hambsch, Peter; Pietsch, Torsten; Bisdas, Sotirios; Platten, Michael; Glas, Martin; Seidel, Clemens; Herrlinger, Ulrich; Hölzel, Michael
Lack of Ecto-5′-Nucleotidase Protects Sensitized Mice against Allergen Challenge
2022-01-01 Caiazzo, E.; Cerqua, I.; Turiello, R.; Riemma, M. A.; De Palma, G.; Ialenti, A.; Roviezzo, F.; Morello, S.; Cicala, C.
Serum CD73 is a prognostic factor in patients with metastatic melanoma and is associated with response to anti-PD-1 therapy
2020-01-01 Turiello, R.; Capone, M.; Giannarelli, D.; Morretta, E.; Monti, M. C.; Madonna, G.; Mallardo, D.; Festino, L.; Azzaro, R.; Levesque, M. P.; Imhof, L.; Weide, B.; Amaral, T.; Chevrier, M.; Sucker, A.; Rutkowski, P.; Schadendorf, D.; Lebbe, C.; Luke, J. J.; Wistuba-Hamprecht, K.; Dummer, R.; Pinto, A.; Morello, S.; Ascierto, P. A.
Thrombo-Inflammation: A Focus on NTPDase1/CD39
2021-01-01 Morello, Silvana; Caiazzo, Elisabetta; Turiello, Roberta; Cicala, Carla
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A2A Receptor Contributes to Tumor Progression in P2X7 Null Mice | 1-gen-2022 | De Marchi, Elena; Pegoraro, Anna; Turiello, Roberta; Di Virgilio, Francesco; Morello, Silvana; Adinolfi, Elena | |
| Adenosine Signaling in the Tumor Microenvironment | 1-gen-2021 | Antonioli, Luca; Fornai, Matteo; Pellegrini, Carolina; D'Antongiovanni, Vanessa; Turiello, Roberta; Morello, Silvana; Haskó, György; Blandizzi, Corrado | |
| CD73: A Promising Biomarker in Cancer Patients | 1-gen-2020 | Turiello, R.; Pinto, A.; Morello, S. | |
| Enzyme activity of circulating CD73 in human serum | 1-gen-2019 | Morello, S.; Turiello, R.; Madonna, G.; Pinto, A.; Ascierto, P. A.; Capone, M. | |
| Exacerbation of Allergic Airway Inflammation in Mice Lacking ECTO-5′-Nucleotidase (CD73) | 1-gen-2020 | Caiazzo, E.; Cerqua, I.; Riemma, M. A.; Turiello, R.; Ialenti, A.; Schrader, J.; Fiume, G.; Caiazza, C.; Roviezzo, F.; Morello, S.; Cicala, C. | |
| Exosomal CD73 from serum of patients with melanoma suppresses lymphocyte functions and is associated with therapy resistance to anti-PD-1 agents | 1-gen-2022 | Turiello, R.; Capone, M.; Morretta, E.; Monti, M. C.; Madonna, G.; Azzaro, R.; Del Gaudio, P.; Simeone, E.; Sorrentino, A.; Ascierto, P. A.; Morello, S. | |
| Frequency of circulating CD8+CD73+T cells is associated with survival in nivolumab-treated melanoma patients | 1-gen-2020 | Capone, M.; Fratangelo, F.; Giannarelli, D.; Sorrentino, C.; Turiello, R.; Zanotta, S.; Galati, D.; Madonna, G.; Tuffanelli, M.; Scarpato, L.; Grimaldi, A. M.; Esposito, A.; Azzaro, R.; Pinto, A.; Cavalcanti, E.; Pinto, A.; Morello, S.; Ascierto, P. A. | |
| L-RNA aptamer-based CXCL12 inhibition combined with radiotherapy in newly-diagnosed glioblastoma: dose escalation of the phase I/II GLORIA trial | 1-gen-2024 | Giordano, Frank A.; Layer, Julian P.; Leonardelli, Sonia; Friker, Lea L.; Turiello, Roberta; Corvino, Dillon; Zeyen, Thomas; Schaub, Christina; Müller, Wolf; Sperk, Elena; Schmeel, Leonard Christopher; Sahm, Katharina; Oster, Christoph; Kebir, Sied; Hambsch, Peter; Pietsch, Torsten; Bisdas, Sotirios; Platten, Michael; Glas, Martin; Seidel, Clemens; Herrlinger, Ulrich; Hölzel, Michael | |
| Lack of Ecto-5′-Nucleotidase Protects Sensitized Mice against Allergen Challenge | 1-gen-2022 | Caiazzo, E.; Cerqua, I.; Turiello, R.; Riemma, M. A.; De Palma, G.; Ialenti, A.; Roviezzo, F.; Morello, S.; Cicala, C. | |
| Serum CD73 is a prognostic factor in patients with metastatic melanoma and is associated with response to anti-PD-1 therapy | 1-gen-2020 | Turiello, R.; Capone, M.; Giannarelli, D.; Morretta, E.; Monti, M. C.; Madonna, G.; Mallardo, D.; Festino, L.; Azzaro, R.; Levesque, M. P.; Imhof, L.; Weide, B.; Amaral, T.; Chevrier, M.; Sucker, A.; Rutkowski, P.; Schadendorf, D.; Lebbe, C.; Luke, J. J.; Wistuba-Hamprecht, K.; Dummer, R.; Pinto, A.; Morello, S.; Ascierto, P. A. | |
| Thrombo-Inflammation: A Focus on NTPDase1/CD39 | 1-gen-2021 | Morello, Silvana; Caiazzo, Elisabetta; Turiello, Roberta; Cicala, Carla |